$40 Billion COVID Vaccine Market in 2021: These 3 Stocks Are Likely to Be the Biggest WinnersThe Motley Fool • 12/08/20
Canada Doubles Its Commitment to Moderna's Coronavirus Vaccine to 40 Million DosesThe Motley Fool • 12/07/20
Moderna's stock rallies after Canada doubles order for COVID-19 vaccine candidateMarket Watch • 12/07/20
Moderna, Inc. (MRNA) CEO Stéphane Bancel Presents at NASDAQ 43rd Virtual Investor Conference (Transcript)Seeking Alpha • 12/04/20
Moderna to provide Israel health ministry with additional 4 million doses of its COVID-19 vaccine candidateMarket Watch • 12/04/20
Moderna Announces Amendment to Supply Agreement with the Ministry of Health of Israel to Supply Additional Doses of mRNA Vaccine Against COVID-19 (mRNA-1273)Business Wire • 12/04/20
Moderna's vaccine candidate has ‘potential' to confer longer-term immunity, company saysMarket Watch • 12/03/20
Moderna Provides Updates on the Clinical Development and Production of Its COVID-19 Vaccine CandidateBusiness Wire • 12/03/20
What Happens Next for Moderna's and Pfizer's Coronavirus Vaccine CandidatesThe Motley Fool • 12/03/20
Should You Worry About This News in Moderna's Investigational Coronavirus Vaccine Report?The Motley Fool • 12/03/20